Q2 FY2026 EarningsQ2 FY2026 results showed a top-line beat but significant bottom-line miss, with revenue reaching a record $78.1M (+23.9% YoY) slightly ahead of the $78.0M consensus. GAAP EPS of $0.07 substantially missed the $0.12 consensus due to a shift toward less capital-intensive services and the conclusion of a high-margin ventilator return program. Management raised the low end of FY26 revenue guidance to $314M-$320M while narrowing Adjusted EBITDA guidance lower to $64M-$68M.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Viemed Healthcare(VMD) the Revenue is 78.1 M (+23.85%), Beat estimate;the EBIT is 4.461 M (-12.44%), Miss estimate;the EPS is 0.07 (-12.5%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.08B23.85%
0.08B23.70%
+0.00B0.15%
EBITMiss expectations
0.00B12.44%
0.01B38.37%
-0.00B50.81%
EPSMiss expectations
0.0712.50%
0.1250.00%
-0.050062.50%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf